As the Presbyopia/Cataracts Venture Leader of the Disease Interception Accelerator (DIA), Eric George leads the team’s efforts in exploring solutions aimed at stopping the progression of presbyopia and cataracts.
Prior to joining the DIA, Eric worked for Johnson & Johnson (J&J) Vision Care for more than ten years. His experience in material and polymer sciences led to key achievements in the manufacturing and development of the ACUVUE® Brand Contact Lenses. Eric also led competitive and intellectual property assessment of medical breakthroughs in ophthalmology while at Vision Care.
Before his time with J&J, Eric served as Research Scientist, Global Technology Leader and Chief Technology Officer in positions at Royal Dutch Shell, Warner Lambert, General Electric, and Zeus Inc., where he authored several patents and led the commercialization of an array of engineering thermoplastics. He is the author or coauthor of 30 issued patents and 14 publications in scientific journals.
Eric earned a Bachelor of Science in Polymer Science from the University of Southern Mississippi and a Ph.D. in Polymer Science and Engineering from the University of Massachusetts at Amherst.